William Pelham to Methylphenidate
This is a "connection" page, showing publications William Pelham has written about Methylphenidate.
Connection Strength
11.302
-
Merrill BM, Macphee FL, Burrows-MacLean L, Coles EK, Wymbs BT, Chacko A, Walker K, Wymbs F, Garefino A, Robb Mazzant J, Gnagy EM, Waxmonsky JG, Massetti GM, Waschbusch DA, Fabiano GA, Pelham WE. Single and Combined Effects of Multiple Intensities of Behavioral Modification and Methylphenidate for Children with ADHD in the Home Setting. Res Child Adolesc Psychopathol. 2023 10; 51(10):1481-1495.
Score: 0.869
-
Pelham WE, Altszuler AR, Merrill BM, Raiker JS, Macphee FL, Ramos M, Gnagy EM, Greiner AR, Coles EK, Connor CM, Lonigan CJ, Burger L, Morrow AS, Zhao X, Swanson JM, Waxmonsky JG, Pelham WE. The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. J Consult Clin Psychol. 2022 May; 90(5):367-380.
Score: 0.802
-
Merrill BM, Raiker JS, Mattfeld AT, Macphee FL, Ramos MC, Zhao X, Altszuler AR, Schooler JW, Coxe S, Gnagy EM, Greiner AR, Coles EK, Pelham WE. Mind-Wandering and Childhood ADHD: Experimental Manipulations across Laboratory and Naturalistic Settings. Res Child Adolesc Psychopathol. 2022 09; 50(9):1139-1149.
Score: 0.793
-
Merrill BM, Raiker JS, Evans SW, Gnagy EM, Pelham WE. Cognitive mechanisms of methylphenidate in ADHD: Do improvements in sustained attention mediate behavioral improvements in the natural environment? Child Neuropsychol. 2021 05; 27(4):425-446.
Score: 0.735
-
Campez M, Raiker JS, Little K, Altszuler AR, Merrill BM, Macphee FL, Gnagy EM, Greiner AR, Musser ED, Coles EK, Pelham WE. An evaluation of the effect of methylphenidate on working memory, time perception, and choice impulsivity in children with ADHD. Exp Clin Psychopharmacol. 2022 Apr; 30(2):209-219.
Score: 0.734
-
Waxmonsky JG, Pelham WE, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. J Am Acad Child Adolesc Psychiatry. 2020 12; 59(12):1330-1341.
Score: 0.666
-
Beery SH, Quay HC, Pelham WE. Differential Response to Methylphenidate in Inattentive and Combined Subtype ADHD. J Atten Disord. 2017 01; 21(1):62-70.
Score: 0.538
-
Pelham WE, Smith BH, Evans SW, Bukstein O, Gnagy EM, Greiner AR, Sibley MH. The Effectiveness of Short- and Long-Acting Stimulant Medications for Adolescents With ADHD in a Naturalistic Secondary School Setting. J Atten Disord. 2017 01; 21(1):40-45.
Score: 0.538
-
Pelham WE, Meichenbaum DL, Smith BH, Sibley MH, Gnagy EM, Bukstein O. Acute Effects of MPH on the Parent-Teen Interactions of Adolescents With ADHD. J Atten Disord. 2017 01; 21(2):158-167.
Score: 0.538
-
Pelham WE, Gnagy EM, Sibley MH, Kipp HL, Smith BH, Evans SW, Bukstein O. Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD. J Atten Disord. 2017 01; 21(2):129-136.
Score: 0.538
-
Helseth SA, Waschbusch DA, Gnagy EM, Onyango AN, Burrows-MacLean L, Fabiano GA, Coles EK, Chacko A, Wymbs BT, Walker KS, Wymbs FA, Garefino A, Massetti GM, Robb Mazzant J, Hoffman MT, Waxmonsky JG, Nichols-Lopez K, Pelham WE. Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controls. J Consult Clin Psychol. 2015 Apr; 83(2):280-292.
Score: 0.481
-
Pelham WE, Burrows-MacLean L, Gnagy EM, Fabiano GA, Coles EK, Wymbs BT, Chacko A, Walker KS, Wymbs F, Garefino A, Hoffman MT, Waxmonsky JG, Waschbusch DA. A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD. J Abnorm Child Psychol. 2014 Aug; 42(6):1019-31.
Score: 0.469
-
Pelham WE, Waxmonsky JG, Schentag J, Ballow CH, Panahon CJ, Gnagy EM, Hoffman MT, Burrows-MacLean L, Meichenbaum DL, Forehand GL, Fabiano GA, Tresco KE, Lopez-Williams A, Coles EK, Gonz?lez MA. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting. J Atten Disord. 2011 Jan; 15(1):28-35.
Score: 0.349
-
Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005 Jun; 44(6):522-9.
Score: 0.248
-
Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol. 2005 May; 13(2):111-26.
Score: 0.247
-
Pelham WE, Hoza B, Pillow DR, Gnagy EM, Kipp HL, Greiner AR, Waschbusch DA, Trane ST, Greenhouse J, Wolfson L, Fitzpatrick E. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings. J Consult Clin Psychol. 2002 Apr; 70(2):320-35.
Score: 0.199
-
Fosco WD, Rosch KS, Waxmonsky JG, Pelham WE, Hawk LW. Baseline performance moderates stimulant effects on cognition in youth with ADHD. Exp Clin Psychopharmacol. 2021 Aug; 29(4):302-307.
Score: 0.174
-
Pelham WE, Hoza B, Kipp HL, Gnagy EM, Trane ST. Effects of methylphenidate and expectancy of ADHD children's performance, self-evaluations, persistence, and attributions on a cognitive task. Exp Clin Psychopharmacol. 1997 Feb; 5(1):3-13.
Score: 0.139
-
Pelham WE, Fabiano GA, Waxmonsky JG, Greiner AR, Gnagy EM, Pelham WE, Coxe S, Verley J, Bhatia I, Hart K, Karch K, Konijnendijk E, Tresco K, Nahum-Shani I, Murphy SA. Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions. J Clin Child Adolesc Psychol. 2016 Jul-Aug; 45(4):396-415.
Score: 0.130
-
Rosch KS, Fosco WD, Pelham WE, Waxmonsky JG, Bubnik MG, Hawk LW. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder. J Abnorm Child Psychol. 2016 Feb; 44(2):309-21.
Score: 0.130
-
Page TF, Pelham WE, Fabiano GA, Greiner AR, Gnagy EM, Hart KC, Coxe S, Waxmonsky JG, Foster EM, Pelham WE. Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD. J Clin Child Adolesc Psychol. 2016 Jul-Aug; 45(4):416-27.
Score: 0.130
-
Bubnik MG, Hawk LW, Pelham WE, Waxmonsky JG, Rosch KS. Reinforcement enhances vigilance among children with ADHD: comparisons to typically developing children and to the effects of methylphenidate. J Abnorm Child Psychol. 2015 Jan; 43(1):149-61.
Score: 0.121
-
Pelham WE, Carlson C, Sams SE, Vallano G, Dixon MJ, Hoza B. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. J Consult Clin Psychol. 1993 Jun; 61(3):506-515.
Score: 0.108
-
Strand MT, Hawk LW, Bubnik M, Shiels K, Pelham WE, Waxmonsky JG. Improving working memory in children with attention-deficit/hyperactivity disorder: the separate and combined effects of incentives and stimulant medication. J Abnorm Child Psychol. 2012 Oct; 40(7):1193-207.
Score: 0.103
-
Pelham WE, Murphy DA, Vannatta K, Milich R, Licht BG, Gnagy EM, Greenslade KE, Greiner AR, Vodde-Hamilton M. Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. J Consult Clin Psychol. 1992 Apr; 60(2):282-292.
Score: 0.100
-
Pelham WE, Waschbusch DA, Hoza B, Gnagy EM, Greiner AR, Sams SE, Vallano G, Majumdar A, Carter RL. Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects. J Abnorm Child Psychol. 2011 Nov; 39(8):1085-98.
Score: 0.097
-
Ashare RL, Hawk LW, Shiels K, Rhodes JD, Pelham WE, Waxmonsky JG. Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder. Psychophysiology. 2010 Sep; 47(5):838-45.
Score: 0.086
-
Pelham WE, McBurnett K, Harper GW, Milich R, Murphy DA, Clinton J, Thiele C. Methylphenidate and baseball playing in ADHD children: who's on first? J Consult Clin Psychol. 1990 Feb; 58(1):130-133.
Score: 0.086
-
Shiels K, Hawk LW, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE, Waxmonsky JG, Gangloff BP. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2009 Oct; 17(5):291-301.
Score: 0.084
-
Spencer SV, Hawk LW, Richards JB, Shiels K, Pelham WE, Waxmonsky JG. Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol. 2009 Aug; 37(6):805-16.
Score: 0.083
-
King S, Waschbusch DA, Pelham WE, Frankland BW, Andrade BF, Jacques S, Corkum PV. Social information processing in elementary-school aged children with ADHD: medication effects and comparisons with typical children. J Abnorm Child Psychol. 2009 May; 37(4):579-89.
Score: 0.081
-
Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):501-510.
Score: 0.081
-
Leddy JJ, Waxmonsky JG, Salis RJ, Paluch RA, Gnagy EM, Mahaney P, Erbe R, Pelham WE, Epstein LH. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):127-36.
Score: 0.081
-
Waxmonsky J, Pelham WE, Gnagy E, Cummings MR, O'Connor B, Majumdar A, Verley J, Hoffman MT, Massetti GA, Burrows-MacLean L, Fabiano GA, Waschbusch DA, Chacko A, Arnold FW, Walker KS, Garefino AC, Robb JA. The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol. 2008 Dec; 18(6):573-88.
Score: 0.079
-
Waschbusch DA, Craig R, Pelham WE, King S. Self-handicapping prior to academic-oriented tasks in children with attention deficit/hyperactivity disorder (ADHD): medication effects and comparisons with controls. J Abnorm Child Psychol. 2007 Apr; 35(2):275-86.
Score: 0.069
-
Wells KC, Chi TC, Hinshaw SP, Epstein JN, Pfiffner L, Nebel-Schwalm M, Owens EB, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March J, Newcorn JH, Pelham WE, Severe JB, Swanson J, Vitiello B, Wigal T. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006 Aug; 74(4):649-57.
Score: 0.067
-
Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep; 162(9):1628-36.
Score: 0.063
-
Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, Rancurello M. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar; 44(3):249-57.
Score: 0.061
-
Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB, Comarda A, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hindshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003 Aug; 71(4):713-27.
Score: 0.055
-
Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33.
Score: 0.053
-
Chronis AM, Pelham WE, Gnagy EM, Roberts JE, Aronoff HR. The impact of late-afternoon stimulant dosing for children with ADHD on parent and parent-child domains. J Clin Child Adolesc Psychol. 2003 Mar; 32(1):118-26.
Score: 0.053
-
Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Chuang SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson JM. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol. 2003; 13(2):123-36.
Score: 0.052
-
Hawk LW, Yartz AR, Pelham WE, Lock TM. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Psychopharmacology (Berl). 2003 Jan; 165(2):118-27.
Score: 0.052
-
Hawk LW, Fosco WD, Colder CR, Waxmonsky JG, Pelham WE, Rosch KS. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition. J Child Psychol Psychiatry. 2018 12; 59(12):1271-1281.
Score: 0.038
-
Smith BH, Pelham WE, Evans S, Gnagy E, Molina B, Bukstein O, Greiner A, Myak C, Presnell M, Willoughby M. Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention-deficit hyperactivity disorder. Exp Clin Psychopharmacol. 1998 May; 6(2):187-204.
Score: 0.038
-
Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDERMOTT MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):180-188.
Score: 0.019
-
Daviss WB, Patel NC, Robb AS, McDERMOTT MP, Bukstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):189-198.
Score: 0.019
-
Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry. 2006 May; 47(5):446-56.
Score: 0.017
-
Smith BH, Pelham WE, Gnagy E, Molina B, Evans S. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2000 Jun; 68(3):489-499.
Score: 0.011